Skip Nav Destination
Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)
Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance
Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial
Issue Archive
November 15 2007
Table of Contents
INSIDE BLOOD
REVIEW IN TRANSLATIONAL HEMATOLOGY
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
CLINICAL TRIALS AND OBSERVATIONS
Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)
Clinical Trials & Observations
Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia
Clinical Trials & Observations
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance
Clinical Trials & Observations
Hagop M. Kantarjian,Francis Giles,Norbert Gattermann,Kapil Bhalla,Giuliana Alimena,Francesca Palandri,Gert J. Ossenkoppele,Franck-Emmanuel Nicolini,Stephen G. O'Brien,Mark Litzow,Ravi Bhatia,Francisco Cervantes,Ariful Haque,Yaping Shou,Debra J. Resta,Aaron Weitzman,Andreas Hochhaus,Philipp le Coutre
Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing
Clinical Trials & Observations
Amy D. Klion,Jamie Robyn,Irina Maric,Weiming Fu,Laura Schmid,Steven Lemery,Pierre Noel,Melissa A. Law,Marilyn Hartsell,Cheryl Talar-Williams,Michael P. Fay,Cynthia E. Dunbar,Thomas B. Nutman
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial
Brief Report
Paul G. Richardson,Pieter Sonneveld,Michael Schuster,David Irwin,Edward Stadtmauer,Thierry Facon,Jean-Luc Harousseau,Dina Ben-Yehuda,Sagar Lonial,Hartmut Goldschmidt,Donna Reece,Jesus San Miguel,Joan Bladé,Mario Boccadoro,Jamie Cavenagh,Melissa Alsina,S. Vincent Rajkumar,Martha Lacy,Andrzej Jakubowiak,William Dalton,Anthony Boral,Dixie-Lee Esseltine,David Schenkein,Kenneth C. Anderson
GENE THERAPY
HEMATOPOIESIS
The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways
Fumihiko Ishikawa,Hiroaki Niiro,Tadafumi Iino,Shuro Yoshida,Noriyuki Saito,Shinya Onohara,Toshihiro Miyamoto,Hiroko Minagawa,Shin-ichiro Fujii,Leonard D. Shultz,Mine Harada,Koichi Akashi
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
The WAVE2/Abi1 complex differentially regulates megakaryocyte development and spreading: implications for platelet biogenesis and spreading machinery
Koji Eto,Hidekazu Nishikii,Takunori Ogaeri,Shiro Suetsugu,Akihide Kamiya,Toshihiro Kobayashi,Daisuke Yamazaki,Atsushi Oda,Tadaomi Takenawa,Hiromitsu Nakauchi
IMMUNOBIOLOGY
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis
Philip O. Scumpia,Matthew J. Delano,Kindra M. Kelly-Scumpia,Jason S. Weinstein,James L. Wynn,Robert D. Winfield,Changqing Xia,Chun Shiang Chung,Alfred Ayala,Mark A. Atkinson,Westley H. Reeves,Michael J. Clare-Salzler,Lyle L. Moldawer
NEOPLASIA
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer–binding protein alpha
Steffen Koschmieder,Francesco D'Alò,Hanna Radomska,Christine Schöneich,Ji Suk Chang,Marina Konopleva,Susumu Kobayashi,Elena Levantini,Nanjoo Suh,Annalisa Di Ruscio,Maria Teresa Voso,Julie C. Watt,Ramasamy Santhanam,Bülent Sargin,Hagop Kantarjian,Michael Andreeff,Michael B. Sporn,Danilo Perrotti,Wolfgang E. Berdel,Carsten Müller-Tidow,Hubert Serve,Daniel G. Tenen
Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1
Bas J. Wouters,Meritxell Alberich Jordà,Karen Keeshan,Irene Louwers,Claudia A. J. Erpelinck-Verschueren,Dennis Tielemans,Anton W. Langerak,Yiping He,Yumi Yashiro-Ohtani,Pu Zhang,Christopher J. Hetherington,Roel G. W. Verhaak,Peter J. M. Valk,Bob Löwenberg,Daniel G. Tenen,Warren S. Pear,Ruud Delwel
Histone deacetylase–mediated transcriptional activation reduces proviral loads in HTLV-1–associated myelopathy/tropical spastic paraparesis patients
Agnès Lezin,Nicolas Gillet,Stéphane Olindo,Aïssatou Signaté,Nathalie Grandvaux,Olivier Verlaeten,Gildas Belrose,Marcelo de Carvalho Bittencourt,John Hiscott,Becca Asquith,Arsène Burny,Didier Smadja,Raymond Césaire,Luc Willems
Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis
Ronan Chaligné,Chloé James,Carole Tonetti,Rodolphe Besancenot,Jean Pierre Le Couédic,Fanny Fava,Fréderic Mazurier,Isabelle Godin,Karim Maloum,Frédéric Larbret,Yann Lécluse,William Vainchenker,Stéphane Giraudier
MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts
Sonia Vallet,Noopur Raje,Kenji Ishitsuka,Teru Hideshima,Klaus Podar,Shweta Chhetri,Samantha Pozzi,Iris Breitkreutz,Tanyel Kiziltepe,Hiroshi Yasui,Enrique M. Ocio,Norihiko Shiraishi,Janice Jin,Yutaka Okawa,Hiroshi Ikeda,Siddhartha Mukherjee,Nileshwari Vaghela,Diana Cirstea,Marco Ladetto,Mario Boccadoro,Kenneth C. Anderson
PHAGOCYTES
RED CELLS
TRANSPLANTATION
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
Smita Bhatia,Liton Francisco,Andrea Carter,Can-Lan Sun,K. Scott Baker,James G. Gurney,Philip B. McGlave,Auayporn Nademanee,Margaret O'Donnell,Norma K. C. Ramsay,Leslie L. Robison,David Snyder,Anthony Stein,Stephen J. Forman,Daniel J. Weisdorf
CORRESPONDENCE
-
Cover Image
Cover Image
A pretreatment FDG-PDT scan in a patient with Burkitt lymphoma. See the related article by Seam et al, beginning on page 3507.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement
Email alerts
Advertisement